| Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival C Joseph, M Alsaleem, N Orah, PL Narasimha, IM Miligy, S Kurozumi, ... Breast cancer research and treatment 182, 267-282, 2020 | 109 | 2020 |
| Breast cancer intratumour heterogeneity: current status and clinical implications C Joseph, A Papadaki, M Althobiti, M Alsaleem, MA Aleskandarany, ... Histopathology 73 (5), 717-731, 2018 | 85 | 2018 |
| Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast MS Toss, I Miligy, A Al-Kawaz, M Alsleem, H Khout, PC Rida, R Aneja, ... Modern Pathology 31 (8), 1226-1236, 2018 | 84 | 2018 |
| The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts M Alsaleem, MS Toss, C Joseph, M Aleskandarany, S Kurozumi, ... Modern Pathology 32 (7), 967-976, 2019 | 55 | 2019 |
| Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers A Ogden, S Bhattarai, B Sahoo, NP Mongan, M Alsaleem, AR Green, ... Scientific reports 10 (1), 3009, 2020 | 46 | 2020 |
| The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer YA Kariri, M Alsaleem, C Joseph, S Alsaeed, A Aljohani, S Shiino, ... Breast Cancer Research and Treatment 185, 293-305, 2021 | 40 | 2021 |
| Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast … S Kurozumi, M Alsaleem, CJ Monteiro, K Bhardwaj, SEP Joosten, T Fujii, ... Breast Cancer Research 22, 1-11, 2020 | 40 | 2020 |
| A novel prognostic two-gene signature for triple negative breast cancer MA Alsaleem, G Ball, MS Toss, S Raafat, M Aleskandarany, C Joseph, ... Modern Pathology 33 (11), 2208-2220, 2020 | 39 | 2020 |
| PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression T Gagliano, K Shah, S Gargani, L Lao, M Alsaleem, J Chen, V Ntafis, ... The Journal of clinical investigation 130 (6), 3188-3204, 2020 | 38 | 2020 |
| A key genomic subtype associated with lymphovascular invasion in invasive breast cancer S Kurozumi, C Joseph, S Sonbul, S Alsaeed, Y Kariri, A Aljohani, S Raafat, ... British journal of cancer 120 (12), 1129-1136, 2019 | 37 | 2019 |
| Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer YA Kariri, C Joseph, S Kurozumi, MS Toss, M Alsaleem, S Raafat, ... Breast cancer research and treatment 179, 349-357, 2020 | 29 | 2020 |
| Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer Y Kariri, MS Toss, M Alsaleem, KA Elsharawy, C Joseph, NP Mongan, ... Breast cancer research and treatment 192 (3), 529-539, 2022 | 27 | 2022 |
| Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers R Ali, A Alblihy, IM Miligy, ML Alabdullah, M Alsaleem, MS Toss, ... Oncogene 40 (14), 2496-2508, 2021 | 23 | 2021 |
| The ITIM-containing receptor: leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) modulates immune response and confers poor prognosis in invasive breast carcinoma C Joseph, MA Alsaleem, MS Toss, YA Kariri, M Althobiti, S Alsaeed, ... Cancers 13 (1), 80, 2020 | 23 | 2020 |
| Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer C Joseph, S Al-Izzi, M Alsaleem, S Kurozumi, MS Toss, M Arshad, FQ Goh, ... British Journal of Cancer 121 (9), 776-785, 2019 | 23 | 2019 |
| Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study EA Rakha, M Alsaleem, KA ElSharawy, MS Toss, S Raafat, R Mihai, ... Histopathology 77 (4), 631-645, 2020 | 21 | 2020 |
| Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer AE Harris, VM Metzler, J Lothion-Roy, D Varun, CL Woodcock, DB Haigh, ... Frontiers in endocrinology 13, 1006101, 2022 | 20 | 2022 |
| The METTL3 RNA methyltransferase regulates transcriptional networks in prostate cancer DB Haigh, CL Woodcock, J Lothion-Roy, AE Harris, VM Metzler, ... Cancers 14 (20), 5148, 2022 | 19 | 2022 |
| RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer A Sanz-Moreno, S Palomeras, K Pedersen, B Morancho, T Pascual, ... Breast Cancer Research 23, 1-18, 2021 | 19 | 2021 |
| The characteristics and clinical significance of atypical mitosis in breast cancer A Lashen, MS Toss, M Alsaleem, AR Green, NP Mongan, E Rakha Modern Pathology 35 (10), 1341-1348, 2022 | 18 | 2022 |
Emad RakhaProfessor of Breast Pathology, Nottingham UniversityVerified email at nottingham.ac.uk
